1 asset in Ependymal Tumor
Therapeutic assets addressing Ependymal Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Ulixertinib Ependymal Tumor | National Cancer Institute (NCI) | P2 | CCC (53) |
Therapeutic assets addressing Ependymal Tumor, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
Ulixertinib Ependymal Tumor | National Cancer Institute (NCI) | P2 | CCC (53) |